Year |
Citation |
Score |
2023 |
Petővári G, Tóth G, Turiák L, L Kiss A, Pálóczi K, Sebestyén A, Pesti A, Kiss A, Baghy K, Dezső K, Füle T, Tátrai P, Kovalszky I, Reszegi A. Dynamic Interplay in Tumor Ecosystems: Communication between Hepatoma Cells and Fibroblasts. International Journal of Molecular Sciences. 24. PMID 37762298 DOI: 10.3390/ijms241813996 |
0.698 |
|
2020 |
Karászi K, Vigh R, Máthé M, Fullár A, Oláh L, Füle T, Papp Z, Kovalszky I. Aberrant Expression of Syndecan-1 in Cervical Cancers. Pathology Oncology Research : Por. PMID 32388727 DOI: 10.1007/S12253-020-00816-0 |
0.651 |
|
2015 |
Szabo S, Mody M, Romero R, Xu Y, Karaszi K, Mihalik N, Xu Z, Bhatti G, Fule T, Hupuczi P, Krenacs T, Rigo J, Tarca AL, Hassan SS, Chaiworapongsa T, et al. Activation of Villous Trophoblastic p38 and ERK1/2 Signaling Pathways in Preterm Preeclampsia and HELLP Syndrome. Pathology Oncology Research : Por. 21: 659-68. PMID 25583406 DOI: 10.1007/S12253-014-9872-9 |
0.54 |
|
2014 |
Dudás J, Bocsi J, Fullár A, Baghy K, Füle T, Kudaibergenova S, Kovalszky I. Heparin and liver heparan sulfate can rescue hepatoma cells from topotecan action. Biomed Research International. 2014: 765794. PMID 25309924 DOI: 10.1155/2014/765794 |
0.57 |
|
2013 |
Szabo S, Xu Y, Romero R, Fule T, Karaszi K, Bhatti G, Varkonyi T, Varkonyi I, Krenacs T, Dong Z, Tarca AL, Chaiworapongsa T, Hassan SS, Papp Z, Kovalszky I, et al. Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome. Virchows Archiv : An International Journal of Pathology. 463: 445-58. PMID 23807541 DOI: 10.1007/S00428-013-1426-0 |
0.553 |
|
2012 |
Péterfia B, Füle T, Baghy K, Szabadkai K, Fullár A, Dobos K, Zong F, Dobra K, Hollósi P, Jeney A, Paku S, Kovalszky I. Syndecan-1 enhances proliferation, migration and metastasis of HT-1080 cells in cooperation with syndecan-2. Plos One. 7: e39474. PMID 22745764 DOI: 10.1371/Journal.Pone.0039474 |
0.703 |
|
2011 |
Than NG, Romero R, Meiri H, Erez O, Xu Y, Tarquini F, Barna L, Szilagyi A, Ackerman R, Sammar M, Fule T, Karaszi K, Kovalszky I, Dong Z, Kim CJ, et al. PP13, maternal ABO blood groups and the risk assessment of pregnancy complications. Plos One. 6: e21564. PMID 21799738 DOI: 10.1371/Journal.Pone.0021564 |
0.495 |
|
2011 |
Szabó B, Nelhubel GA, Kárpáti A, Kenessey I, Jóri B, Székely C, Peták I, Lotz G, Hegedus Z, Hegedus B, Füle T, Döme B, Tímár J, Tóvári J. Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas. Oral Oncology. 47: 487-96. PMID 21498106 DOI: 10.1016/J.Oraloncology.2011.03.020 |
0.33 |
|
2009 |
Moskovszky L, Szuhai K, Krenács T, Hogendoorn PC, Szendroi M, Benassi MS, Kopper L, Füle T, Sápi Z. Genomic instability in giant cell tumor of bone. A study of 52 cases using DNA ploidy, relocalization FISH, and array-CGH analysis. Genes, Chromosomes & Cancer. 48: 468-79. PMID 19242928 DOI: 10.1002/Gcc.20656 |
0.359 |
|
2008 |
Than NG, Abdul Rahman O, Magenheim R, Nagy B, Fule T, Hargitai B, Sammar M, Hupuczi P, Tarca AL, Szabo G, Kovalszky I, Meiri H, Sziller I, Rigo J, Romero R, et al. Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome. Virchows Archiv : An International Journal of Pathology. 453: 387-400. PMID 18791734 DOI: 10.1007/S00428-008-0658-X |
0.525 |
|
2008 |
Kulka J, Kovalszky I, Svastics E, Berta M, Füle T. Lymphoepithelioma-like carcinoma of the breast: not Epstein-Barr virus-, but human papilloma virus-positive. Human Pathology. 39: 298-301. PMID 18206498 DOI: 10.1016/J.Humpath.2007.08.006 |
0.581 |
|
2007 |
Szarvas T, Kovalszky I, Bedi K, Szendroi A, Majoros A, Riesz P, Füle T, László V, Kiss A, Romics I. Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment. Oncology Reports. 18: 405-9. PMID 17611663 |
0.647 |
|
2007 |
Szarvas T, Kovalszky I, Bedi K, Szendroi A, Majoros A, Riesz P, Füle T, László V, Kiss A, Romics I. Deletion analysis of tumor and urinary DNA to detect bladder cancer: Urine supernatant versus urine sediment Oncology Reports. 18: 405-409. DOI: 10.3892/Or.18.2.405 |
0.661 |
|
2006 |
Füle T, Máthé M, Suba Z, Csapó Z, Szarvas T, Tátrai P, Paku S, Kovalszky I. The presence of human papillomavirus 16 in neural structures and vascular endothelial cells. Virology. 348: 289-96. PMID 16499942 DOI: 10.1016/J.Virol.2005.12.043 |
0.7 |
|
2006 |
Máthé M, Suba Z, Németh Z, Tátrai P, Füle T, Borgulya G, Barabás J, Kovalszky I. Stromal syndecan-1 expression is an adverse prognostic factor in oral carcinomas. Oral Oncology. 42: 493-500. PMID 16364677 DOI: 10.1016/J.Oraloncology.2005.10.003 |
0.706 |
|
2006 |
Füle T, Csapó Z, Máthé M, Tátrai P, László V, Papp Z, Kovalszky I. Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes. Gynecologic Oncology. 100: 570-8. PMID 16325245 DOI: 10.1016/J.Ygyno.2005.09.019 |
0.682 |
|
2002 |
Füle T, Kovalszky I. [The molecular diagnostics of viruses]. Magyar Onkologia. 46: 17-22. PMID 12050678 |
0.497 |
|
Show low-probability matches. |